The Department of Health and Human Services on Wednesday gave compounding pharmacies the go-ahead to make and sell six peptides, according to a report by Joseph Choi for The Hill. The outlet reported that the action came without finalizing any new approvals or regulatory changes.

NPR reported that the department will let small compounding pharmacies make six peptides that the Food and Drug Administration has not approved. Its report, written by Sydney Lupkin, said the allowance may not be enough to meet demand.

The accounts differ in timing and in who is credited with the decision. The Hill described an action taken on Wednesday, while NPR described a measure the department will allow. NPR's headline attributes the move to the Trump administration. A video report by Adam Yamaguchi for CBS News frames the matter as a push by Health and Human Services Secretary Robert F. Kennedy Jr. for pharmacies to produce non-FDA approved peptides.

The source summaries do not name the six peptides or the pharmacies that will be affected, and they do not state how many pharmacies are involved. The Hill's account emphasizes that no new approvals or regulatory changes were finalized, while NPR's account focuses on small compounding pharmacies and on whether the allowance will meet demand. Information on how the decision will be carried out is not contained in the summaries available for this report.

Sources: The Hill: HHS gives compounding pharmacies free rein to make certain peptides; NPR: Trump administration will allow pharmacies to make popular peptides; CBS News: Inside RFK Jr.'s push for pharmacies to make non-FDA approved peptides.